Combined radiation and chemotherapy for intrathoracic tumors can produce appreciable morbidity. Apprehension about the severity of these toxicities may inhibit optimal patient care.
Methods
The literature on recognition, diagnosis, prophylaxis, and management of these toxicities is reviewed and combined with the experiences of the authors to produce management recommendations.
Results
Toxicities include acute and chronic esophagitis, early and late pneumonitis with fibrosis, myelosuppression, and neurologic deficits. Measures are available to minimize their severity and to reduce their impact on the patient.
Conclusions
The morbidity of combined radiation and chemotherapy patients with intrathoracic tumors can be minimized by recognizing potential toxicities and by applying appropriate prophylactic and management measures.
Get full access to this article
View all access options for this article.
References
1.
MascarenhasF., SilvestreM., Sa da CostaM.Acute secondary effects in the esophagus in patients undergoing radiation for carcinoma of the lung. Am J Clin Oncol.1989; 12: 34–40.
2.
CoiaL.R., MyersonR.J., TepperJ.E.Late effects of radiotherapy on the gastrointestinal tract. Int J Radiat Oncol Biol Phys.1995; 31: 1213–1236.
3.
DoseA.A.The symptom experience of mucositis, stomatitis, and xerostomia. Semin Oncol Nurs.1995; 11: 248–255.
4.
ChowhanN.M.Injurious effects of radiation on the esophagus. Am J Gastroenterol.1990; 85: 115–120.
5.
QuilitzR.Modulation of chemotherapy-induced mucositis. Pharmacother Forum.1995; 6(1): 2–6.
6.
SwamotoR.Altered nutrition. In: DowK.H., HilderleyL.J., eds. Nursing Care in Radiation Oncology.Philadelphia, Pa: WB Saunders; 1992.
7.
PizzoP.A., MeyersJ., FreifeldA.Infections in the cancer patient. In: DeVitaV.T.Jr, HellmanS., RosenbergS.A., eds. Principles and Practice of Oncology.Philadelphia, Pa: WB Saunders; 1992.
8.
StoverD.Pulmonary toxicity. In: DeVitaV.T.Jr, HellmanS., RosenbergS.A., eds. Important Advances in Oncology.Philadelphia, Pa: JB Lippincott; 1993.
9.
GrossN.J.Pulmonary effects of radiation therapy. Ann Intern Med.1977; 86: 81–92.
10.
GroenH.J., van der MarkT.W., van der LeestA.H.Pulmonary function changes in lung-cancer patients treated with radiation with or without carboplatin. Am J Respir Crit Care Med.1995; 152: 2044–2048.
11.
StrohlR.Ineffective breathing patterns. In: DowK.H., HilderleyL.J., eds. Nursing Care in Radiation Oncology.Philadelphia, Pa: WB Saunders; 1992.
12.
ChoiN.C., KanarekD.J., GrilloH.C.Effect of postoperative radiotherapy on changes in pulmonary function in patients with stage II and IIIA lung carcinoma. Int J Radiat Oncol Biol Phys.1990; 18: 95–99.
13.
CurranW.J.Jr, MoldofskyP.J., SolinL.J.Observations on the predictive value of perfusion lung scans on post-irradiation pulmonary function among 210 patients with bronchogenic carcinoma. Int J Radiat Oncol Biol Phys.1992; 24: 31–36.
14.
AbrattR.P., WillcoxP.A.The effect of irradiation on lung function and perfusion in patients with lung cancer. Int J Radiat Oncol Biol Phys.1995; 31: 915–919.
15.
BoersmaL.J., DamenE.M., de BoerR.W.Estimation of overall pulmonary function after irradiation using dose-effect relations for local functional injury. Radiother Oncol.1995; 36: 15–23.
16.
DubrayB., Henry-AmarH., MeerwaldtJ.H.Radiation-induced lung damage after thoracic irradiation for Hodgkinís disease: the role of fractionation. Radiother Oncol.1995; 36: 211–217.
17.
RoachMIII, GandaraD.R., YuoH.S.Radiation pneumonitis following combined modality therapy for lung cancer: analysis of prognostic factors. J Clin Oncol.1995; 13: 2606–2612.
18.
RubinP., FinkelsteinJ., ShapiroD.Molecular biology mechanisms in the radiation induction of pulmonary injury syndromes: interrelationship between the alveolar macrophage and the septal fibroblast. Int J Radiat Oncol Biol Phys.1992; 24: 93–101.
19.
MaasiltaP., HallmanM., TaskinenE.Bronchoalveolar lavage fluid finding following radiotherapy for non-small cell lung cancer. Int J Radiat Oncol Biol Phys.1993; 26: 117–123.
20.
FinkelsteinJ.N., JohnstonC.J., BaggsR.Early alterations in extracellular matrix and transforming growth factor beta gene expression in mouse lung indicative of late radiation fibrosis. Int J Radiat Oncol Biol Phys.1994; 28: 621–631.
21.
McBrideW.H.Cytokine cascades in late normal tissue radiation responses. Int J Radiat Oncol Biol Phys.1995; 33: 233–234.
22.
RodemannH.P., BambergM.Cellular basis of radiation-induced fibrosis. Radiother Oncol.1995; 35: 83–90.
23.
MominF., KrautM., LattinP.Thrombocytopenia in patients receiving chemoradiotherapy and G-CSF for locally advanced non-small cell lung cancer. Proc Annu Meet Am Soc Clin Oncol.1992; 11: A983.
24.
BunnP.A.Jr, CrowleyJ., HazukaR.The role of GM-CSF in limited stage SCLC: a randomized phase III study of the Southwest Oncology Group (SWOG). Proc Annu Meet Am Soc Clin Oncol.1992; 11: A974. Abstract.
25.
BunnP.A.Jr, CrowleyJ., KellyK.Chemoradiotherapy with or without granulocyte-macrophage colony-stimulating factor in the treatment of limited-stage small -cell lung cancer: a prospective phase III randomized study of the Southwest Oncology Group. J Clin Oncol.1995; 13: 1632–1641.
26.
American Society of Clinical Oncology.Recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. J Clin Oncol.1994; 12: 2471–2508.
27.
NugentJ.L., BunnP.A.Jr, MatthewsM.J.CNS metastases in small cell bronchogenic carcinoma: increasing frequency and changing pattern with lengthening survival. Cancer.1979; 44: 1885–1893.
28.
KristjansenP.E.Should current management of small cell lung cancer include prophylactic cranial irradiation?Lung Cancer.1994; 10(suppl 1): S319–S329.
29.
ArriagadaR., Le ChevalierT., BorieF.Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. J Natl Cancer Inst.1995; 87: 183–190.
30.
CataneR., SchwadeJ., YarrI.Follow-up neurological evaluation in patients with small cell lung carcinoma treated with prophylactic cranial irradiation and chemotherapy. Int J Radiat Oncol Biol Phys.1981; 7: 105–109.
31.
JohnsonB.E., PatronasN., HayesW.Neurologic, computed cranial tomographic, and magnetic resonance imaging abnormalities in patients with small-cell lung cancer: further follow-up of 6- to 13-year survivors. J Clin Oncol.1990; 8: 48–56.
32.
BunnP.A.Jr, KellyK.Prophylactic cranial irradiation for patients with small-cell lung cancer. J Natl Cancer Inst.1995; 87: 161–162.
33.
TurrisiA.T.Brain irradiation and systemic chemotherapy for small-cell lung cancer: dangerous liaisons?J Clin Oncol.1990; 8: 196–199.
34.
KomakiR., MeyersC.A., CoxJ.D.Neuropsychological functioning of patients with small cell lung cancer prior to and shortly following prophylactic cranial irradiation: evidence for pre-existing cognitive impairments. Proc Annu Meet Am Soc Clin Oncol.1993; 12: A1084. Abstract.
35.
CullA., GregorA., HopwoodP.Neurological and cognitive impairment in long-term survivors of small cell lung cancer. Eur J Cancer.1994; 30A: 1067–1074.
36.
van OosterhoutA.G., GanzevlesP., WilminkJ.T.Sequelae in long-term survivors of small cell lung cancer. Int J Radiat Oncol Biol Phys.1996; 34: 1037–1044.
37.
van OosterhoutA.G., van de PolM., ten VeldeG.P.Neurologic disorders in 203 consecutive patients with small cell lung cancer: results of a longitudinal study. Cancer.1996; 77: 1434–1441.
38.
DalmauJ., GrausF., CheungN.K.Major histocompatibility proteins, anti-Hu antibodies, and paraneoplastic encephalomyelitis in neuroblastoma and small cell lung cancer. Cancer.1995; 75: 99–109.
39.
KomakiR.Neurological sequelae in long-term survivors of small cell lung cancer. Int J Radiat Oncol Biol Phys.1996; 34: 1181–1183.
